Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome
This study has been withdrawn prior to enrollment.
(The FDA IND application is paused due to additional required testing. The IRB protocol was closed prior to research starting.)
Information provided by (Responsible Party):
Sean Mackey, Stanford University
First received: March 3, 2009
Last updated: December 9, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||December 2011|
|Estimated Primary Completion Date:||December 2011 (Final data collection date for primary outcome measure)|